After discovering that he held the LRRK2 mutation on his twelfth chromosome (indicating that his lifetime risk of developing Parkinson’s disease is 30-75% rather than the typical 1%), Google co-founder Sergey Brin became one of the first philanthropists to fund research into a disease based on the results of a genetic test. In Thomas Goetz’s comprehensive profile of Brin and his fight against Parkinson’s disease and Parkinson’s science, we are shown how Sergey Brin wants to change how disease research is conducted: